BUND FINANCE

BUND FINANCE › Stocks › BDX

Becton, Dickinson and Company (BDX)

NYSE · Stock price, chart and technical analysis

US$212.68-3.40 (-1.57%)

Data from Financial Modeling Prep · Nov 19, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$216.08
OpenUS$215.23
Day rangeUS$211.63 – US$216.26
52-week rangeUS$140.11 – US$220.36
Market capUS$57.93B
Volume2.57M
50-day averageUS$193.02
200-day averageUS$169.32
Beta0.28
Last dividend per shareUS$3.98

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20222023202420252026
RevenueUS$18.9BUS$19.4BUS$20.2BUS$21.8BUS$19.5B
Net incomeUS$1.8BUS$1.5BUS$1.7BUS$1.7BUS$1.1B
EPS (diluted)5.884.945.865.834.09
Gross margin44.9%42.2%45.2%45.4%47.4%
Operating margin12.1%10.9%11.9%11.8%11.6%
Net margin9.4%7.7%8.5%7.7%5.9%
Free cash flowUS$1.7BUS$2.1BUS$3.1BUS$2.7BUS$2.7B
Total debtUS$17.0BUS$16.8BUS$21.6BUS$19.2BUS$16.3B
CashUS$1.2BUS$1.4BUS$1.9BUS$851.0MUS$725.0M

Compound annual growth: revenue 0.8% · net income -10.4% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E51.4x34.3x26.4x
EV / EBITDA15.5x14.7x16.3x
Operating margin11.8%—3.6%
Net margin5.7%—-0.0%
Debt / equity1.06—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Becton, Dickinson and Company

SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
CEOThomas E. Polen Jr.
Employees60,000
IPO date1973-02-21

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and ad…

www.bd.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice